137 related articles for article (PubMed ID: 7760428)
21. Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis.
Foti A; Ahuja HG; Allen SL; Koduru P; Schuster MW; Schulman P; Bar-Eli M; Cline MJ
Blood; 1991 Jun; 77(11):2441-4. PubMed ID: 2039825
[TBL] [Abstract][Full Text] [Related]
22. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of the rearrangement of the bcr/abl gene in extramedullary (lymph nodes) blast crisis diagnosed in chronic myeloid leukaemia.
González FA; Villegas A; Ferro MT; Cabello P; Morales D; Perez J; Martinez R
Br J Haematol; 1993 Jun; 84(2):351-2. PubMed ID: 8398844
[TBL] [Abstract][Full Text] [Related]
24. A splicing mutation accounts for the lack of p53 gene expression in a CML blast crisis cell line: a novel mechanism of p53 gene inactivation.
Foti A; Bar-Eli M; Ahuja HG; Cline MJ
Br J Haematol; 1990 Sep; 76(1):143-5. PubMed ID: 2223633
[TBL] [Abstract][Full Text] [Related]
25. p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long-term cell lines but may be acquired in acute myeloid leukemia cells in vitro.
Sen S; Zhou H; Andersson BS; Cork A; Freireich EJ; Stass SA
Cancer Genet Cytogenet; 1995 Jul; 82(1):35-40. PubMed ID: 7627932
[TBL] [Abstract][Full Text] [Related]
26. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.
Ahuja H; Bar-Eli M; Arlin Z; Advani S; Allen SL; Goldman J; Snyder D; Foti A; Cline M
J Clin Invest; 1991 Jun; 87(6):2042-7. PubMed ID: 2040694
[TBL] [Abstract][Full Text] [Related]
27. Characterization of immunoglobulin heavy chain gene rearrangements in chronic myeloid leukemia with recurrent B-lymphoid blast crisis following bone marrow transplantation.
Kiyoi H; Fukutani H; Kubo K; Ohno R; Naoe T
Intern Med; 1994 Dec; 33(12):786-9. PubMed ID: 7718962
[TBL] [Abstract][Full Text] [Related]
28. Molecular defects associated with the acute phase CML.
Serra A; Guerrasio A; Gaidano G; Rosso C; Rege-Cambrin G; Petroni D; Mazza U; Saglio G
Leuk Lymphoma; 1993; 11 Suppl 1():25-8. PubMed ID: 8251905
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetic and immunogenotypic alterations of blast crisis cells in chronic myelogenous leukemia independently linked to immunophenotypic expression.
Murakami T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Tauchi T; Nakazawa S; Kimura N; Toyama K
Cancer Genet Cytogenet; 1994 Jan; 72(1):48-54. PubMed ID: 8111739
[TBL] [Abstract][Full Text] [Related]
30. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
31. p53 loss and point mutations are associated with suppression of apoptosis and progression of CML into myeloid blastic crisis.
Stuppia L; Calabrese G; Peila R; Guanciali-Franchi P; Morizio E; Spadano A; Palka G
Cancer Genet Cytogenet; 1997 Oct; 98(1):28-35. PubMed ID: 9309115
[TBL] [Abstract][Full Text] [Related]
32. Clonal succession and deletion of bcr/abl sequences in chronic myelogenous leukemia with recurrent lymphoid blast crisis.
Laneuville P; Sullivan AK
Leukemia; 1991 Sep; 5(9):752-6. PubMed ID: 1943228
[TBL] [Abstract][Full Text] [Related]
33. Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemia.
Manley R; Cochrane J; McDonald M; Rigby S; Moore A; Kirk A; Clarke S; Crossen PE; Morris CM; Patton WN
Leukemia; 1999 Jan; 13(1):126-9. PubMed ID: 10049047
[TBL] [Abstract][Full Text] [Related]
34. Changing p53 mutations with the evolution of chronic myeloid leukaemia from the chronic phase to blast crisis.
Guinn BA; Smith M; Padua RA; Burnett A; Mills K
Leuk Res; 1995 Aug; 19(8):519-25. PubMed ID: 7658697
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms in the evolution of chronic myelocytic leukemia.
Cline MJ; Jat PS; Foti A
Leuk Lymphoma; 1992 Jul; 7(4):283-7. PubMed ID: 1493427
[TBL] [Abstract][Full Text] [Related]
36. Southern blot analysis of Bcr, N-ras, H-ras, c-myc and myb proto-oncogenes in blast crisis of chronic myelogenous leukemia.
Naoe T; Doi S; Yamanaka K; Naito K; Nitta M; Yamada K
Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):32-7. PubMed ID: 2741649
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of tumor progression in chronic myeloproliferative disorders.
Gaidano G; Guerrasio A; Serra A; Rege-Cambrin G; Saglio G
Leukemia; 1994 Apr; 8 Suppl 1():S27-9. PubMed ID: 8152300
[TBL] [Abstract][Full Text] [Related]
38. Immunoglobulin and T cell receptor gene rearrangements in Philadelphia chromosome-positive leukemia: a different involvement pattern in blast crisis and acute leukemia.
Ohyashiki JH; Ohyashiki K; Tauchi T; Saito M; Nakazawa S; Kimura N; Toyama K
Leukemia; 1990 Aug; 4(8):572-9. PubMed ID: 2143795
[TBL] [Abstract][Full Text] [Related]
39. [Mutations of the p53 gene in hematologic neoplasms].
Mori N; Mizoguchi H
Nihon Rinsho; 1992 Jun; 50(6):1353-7. PubMed ID: 1518157
[TBL] [Abstract][Full Text] [Related]
40. p53 gene mutation in the chronic phase was not detected in the myeloid crisis of a chronic myelocytic leukemia case.
Kurosawa M; Okabe M; Kunieda Y; Miyazaki T
Blood; 1994 May; 83(9):2750-2. PubMed ID: 8167355
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
